Effects of tactile massage on metabolic biomarkers in patients with type 2 diabetes

Diabetes and Metabolism

Volumn 39, Issue 5, 2013, Pages 411-417

  Wandell P E ^a   Arnlov J ^b,c   Nixon Andreasson, A ^a,d   Andersson, K ^a   Tornkvist L ^a   Carlsson, A C ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c DALARNA UNIVERSITY   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Complementary alternative medicine; Diabetes mellitus; Primary health care; Relaxation; Sweden; Tactile massage

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GHRELIN; HEMOGLOBIN A1C; LEPTIN; SOMATOMEDIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PILOT STUDY; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; RELAXATION EXERCISE; TACTILE MASSAGE; WAIST CIRCUMFERENCE;

APPROCHES COMPLÉMENTAIRES/PARALLÈLES EN SANTÉ; COMPLEMENTARY/ALTERNATIVE MEDICINE; DIABETES MELLITUS; EN SUÈDE; LE DIABÈTE SUCRÉ; LES SOINS DE SANTÉ PRIMAIRES; MASSAGE TACTILE; PRIMARY HEALTH CARE; RELAXATION; SWEDEN; TACTILE MASSAGE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INTENTION TO TREAT ANALYSIS; MALE; MASSAGE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RELAXATION THERAPY; STRESS, PSYCHOLOGICAL; SWEDEN; WAIST CIRCUMFERENCE;

EID: 84885924571     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.02.002     Document Type: Article

References (39)

1. Bjorntorp P., Holm G., Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 1999, 16:373-383.
2. Rosenzweig S., Reibel D.K., Greeson J.M., Edman J.S., Jasser S.A., McMearty K.D., et al. Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study. Altern Ther Health Med 2007, 13:36-38.
3. McGinnis R.A., McGrady A., Cox S.A., Grower-Dowling K.A. Biofeedback-assisted relaxation in type 2 diabetes. Diabetes Care 2005, 28:2145-2149.
4. Lam P., Dennis S.M., Diamond T.H., Zwar N. Improving glycaemic and BP control in type 2 diabetes. The effectiveness of tai chi. Aust Fam Physician 2008, 37:884-887.
5. Tsang T., Orr R., Lam P., Comino E., Singh M.F. Effects of Tai Chi on glucose homeostasis and insulin sensitivity in older adults with type 2 diabetes: a randomised double-blind sham-exercise-controlled trial. Age Ageing 2008, 37:64-71.
6. Andersson K., Wandell P., Tornkvist L. Working with tactile massage--a grounded theory about the energy controlling system. Complement Ther Clin Pract 2007, 13:258-265.
7. Andersson K., Tornkvist L., Wandell P. Tactile massage within the primary health care setting. Complement Ther Clin Pract 2009, 15:158-160.
8. Andersson K., Wändell P., Törnkvist L. Tactile massage improves glycaemic control in women with type 2 diabetes: a pilot study. Practical Diabetes Int 2004, 21:105-109.
9. Wändell P.E., Carlsson A.C., Andersson K., Gåfvels C., Törnkvist L. Tactile massage or relaxation exercises do not improve the metabolic control of type 2 diabetics. Open Diabetes J 2010, 3:6-10.
10. Mostad I.L., Qvigstad E., Bjerve K.S., Grill V.E. Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes. Scand J Clin Lab Invest 2004, 64:565-574.
11. Hui X., Lam K.S., Vanhoutte P.M., Xu A. Adiponectin and cardiovascular health: an update. Br J Pharmacol 2012, 165:574-590.
12. Hasan-Ali H., Abd El-Mottaleb N.A., Hamed H.B., Abd-Elsayed A. Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis. Coron Artery Dis 2011, 22:264-269.
13. Delhanty P.J., van der Lely A.J. Ghrelin and glucose homeostasis. Peptides 2011, 32:2309-2318.
14. Qasim A., Mehta N.N., Tadesse M.G., Wolfe M.L., Rhodes T., Girman C., et al. Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol 2008, 52:231-236.
15. Sattar N., Wannamethee G., Sarwar N., Chernova J., Lawlor D.A., Kelly A., et al. Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol 2009, 53:167-175.
16. Ingelsson E., Larson M.G., Yin X., Wang T.J., Meigs J.B., Lipinska I., et al. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 2008, 93:3149-3157.
17. Nakatochi M., Miyata S., Tanimura D., Izawa H., Asano H., Murase Y., et al. The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study. Diabetes Res Clin Pract 2011, 92:e61-e65.
18. Inoue M., Maehata E., Yano M., Taniyama M., Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005, 54:281-286.
19. Lilja M., Rolandsson O., Norberg M., Soderberg S. The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metabol Syndr Relat Disord 2012, 10:143-151.
20. Oda N., Imamura S., Fujita T., Uchida Y., Inagaki K., Kakizawa H., et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008, 57:268-273.
21. Labruna G., Pasanisi F., Nardelli C., Caso R., Vitale D.F., Contaldo F., et al. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) 2011, 19:1492-1496.
22. Kotani K., Sakane N., Saiga K., Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 2005, 48:2684-2686.
23. Norata G.D., Raselli S., Grigore L., Garlaschelli K., Dozio E., Magni P., et al. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007, 38:2844-2846.
24. Carlsson A.C., Wandell P.E., de Faire U., Hellenius M.L. Risk factors associated with newly diagnosed high blood pressure in men and women. Am J Hypertens 2008, 21:771-777.
25. Gadd M., Johansson S.E., Sundquist J., Wandell P. Morbidity in cardiovascular diseases in immigrants in Sweden. J Intern Med 2003, 254:236-243.
26. Gadd M., Sundquist J., Johansson S.E., Wandell P. Do immigrants have an increased prevalence of unhealthy behaviours and risk factors for coronary heart disease?. Eur J Cardiovasc Prev Rehabil 2005, 12:535-541.
27. Wandell P.E., Carlsson A., Steiner K.H. Prevalence of diabetes among immigrants in the Nordic countries. Curr Diabetes Rev 2010, 6:126-133.
28. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134:663-694.
29. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
30. Lean M.E., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ 1995, 311:158-161.
31. Wandell P.E., Carlsson A.C., Andersson K., Gafvels C., Tornkvist L. Tactile massage or relaxation exercises do not improve the metabolic control of type 2 diabetics. Open Diabetes J 2010, 3:6-10.
32. Jung C.H., Rhee E.J., Choi J.H., Bae J.C., Yoo S.H., Kim W.J., et al. The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy korean male adults. Korean Diabetes J 2010, 34:237-243.
33. Hsu C.H., Liao Y.L., Lin S.C., Chou P. Adiponectin level predicts HDL-cholesterol level in type 2 diabetes. Open Atheroscler Thromb J 2012, 5:1-5.
34. Esch T., Stefano G.B. The neurobiology of stress management. Neuro Endocrinol Lett 2010, 31:19-39.
35. Kaptchuk T.J., Kelley J.M., Conboy L.A., Davis R.B., Kerr C.E., Jacobson E.E., et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008, 336:999-1003.
36. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000participants from 52countries: a case-control study. Lancet 2005, 366:1640-1649.
37. Balkau B., Picard P., Vol S., Fezeu L., Eschwege E. Consequences of change in waist circumference on cardiometabolic risk factors over 9years: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007, 30:1901-1903.
38. Fanghanel G., Sanchez-Reyes L., Felix-Garcia L., Violante-Ortiz R., Campos-Franco E., Alcocer L.A. Impact of waist circumference reduction on cardiovascular risk in treated obese subjects. Cir Cir 2011, 79:175-181.
39. Wandell P.E., Gigante B., Nixon Andreasson A., Carlsson A.C. Gender differences regarding novel biomarkers and metabolic risk factors in metformin treated type 2 diabetic patients. Open Diabetes J 2012, 5:13-19.